Continental Advisors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,892	Closed	-$452K	–	45
2022 Q2	$452K	Hold	24,892	–	–	0.27%	38
2022 Q1	$627K	Hold	24,892	–	–	0.31%	36
2021 Q4	$687K	Hold	24,892	–	–	0.29%	39
2021 Q3	$804K	Sell	24,892 -4,500	-15%	-$145K	0.34%	38
2021 Q2	$899K	Hold	29,392	–	–	0.41%	39
2021 Q1	$895K	Sell	29,392 -7,000	-19%	-$213K	0.41%	38
2020 Q4	$720K	Hold	36,392	–	–	0.33%	41
2020 Q3	$475K	Buy	36,392 +22,500	+162%	+$294K	0.25%	50
2020 Q2	$158K	Hold	13,892	–	–	0.08%	59
2020 Q1	$199K	Hold	13,892	–	–	0.15%	58
2019 Q4	$378K	Hold	13,892	–	–	0.18%	55
2019 Q3	$398K	Hold	13,892	–	–	0.24%	55
2019 Q2	$386K	Hold	13,892	–	–	0.22%	55
2019 Q1	$461K	Sell	13,892 -12,108	-47%	-$402K	0.21%	57
2018 Q4	$756K	Hold	26,000	–	–	0.23%	58
2018 Q3	$1.2M	Hold	26,000	–	–	0.26%	52
2018 Q2	$972K	Hold	26,000	–	–	0.24%	57
2018 Q1	$768K	Hold	26,000	–	–	0.19%	55
2017 Q4	$893K	Sell	26,000 -9,200	-26%	-$316K	0.19%	55
2017 Q3	$1.27M	Sell	35,200 -24,900	-41%	-$901K	0.29%	51
2017 Q2	$1.55M	Hold	60,100	–	–	0.35%	49
2017 Q1	$1.15M	Hold	60,100	–	–	0.26%	62
2016 Q4	$1M	Buy	60,100 +28,000	+87%	+$467K	0.27%	64
2016 Q3	$661K	Buy	+32,100	New	+$661K	0.18%	78